bioAffinity Technologies, Inc.
BIAF- Exchange
- Nasdaq
- Industry
- Services-Commercial Physical & Biological Research
- SEC CIK
- 0001712762
No open-market purchases or sales by bioAffinity Technologies, Inc. insiders were filed in the last 90 days; 20 institutions reported holding it in 13F filings for Q2 2026, worth $782.5K in total; no superinvestor holds it.
Other share classesBIAFW
Q2 2026 vs. Q1 2026
How the institutions holding bioAffinity Technologies, Inc. changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Q2 2026 | Change |
|---|---|---|---|
| Holders | 14 | 20 | +6 |
| Shares | 242.2K | 805.9K | +563.7K (+232.7%) |
| Value | $928.5K | $782.5K | −$146.0K (−15.7%) |
New holders (10)
Institutions that held bioAffinity Technologies, Inc. at the end of Q2 2026 but not at the end of Q1 2026.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Sabby Management, LLC | 365,647 | $296.9K | 2.47% |
| BlackRock, Inc. | 98,777 | $80.2K | 0.00% |
| Susquehanna International Group, LLP | 26,870 | $21.8K | 0.00% |
| Jane Street Group, LLC | 26,784 | $21.7K | 0.00% |
| HRT Financial LP | 20,834 | $16.0K | 0.00% |
| Virtu Financial LLC | 11,113 | $9.00K | 0.00% |
| Parrish Capital LLC | 10,418 | $8.46K | 0.01% |
| Allworth Financial LP | 10,000 | $8.12K | 0.00% |
| Royal Bank of Canada | 931 | $1.00K | 0.00% |
| EMC Capital Management | 2,001 | $1.00K | 0.00% |
Sold out (4)
Institutions that held bioAffinity Technologies, Inc. at the end of Q1 2026 and filed for Q2 2026 without it.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| Schonfeld Strategic Advisors LLC | 24,413 | $93.5K |
| Ameritas Advisory Services, LLC | 1,000 | $3.83K |
| Citigroup Inc | 57 | $218 |
| Caitong International Asset Management Co., Ltd | 1 | $4 |